Merck (MRK) Total Current Liabilities (2009 - 2026)

Merck (MRK) has 18 years of Total Current Liabilities data on file, last reported at $26.9 billion in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $26.9 billion, up 7.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.9 billion (up 7.04% YoY), and the FY2025 annual result was $28.3 billion, changed 0.33% from the prior year.
• Total Current Liabilities declined to $26.9 billion in Q1 2026 per MRK's latest filing, from $28.3 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $29.6 billion in Q3 2024 and troughed at $22.3 billion in Q1 2022.
• A 5-year average of $25.4 billion and a median of $25.2 billion in 2025 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities slipped 15.34% in 2022, then grew 28.11% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $24.2 billion in 2022, then advanced by 6.0% to $25.7 billion in 2023, then rose by 10.61% to $28.4 billion in 2024, then decreased by 0.33% to $28.3 billion in 2025, then slipped by 4.88% to $26.9 billion in 2026.
• Business Quant data shows MRK's Total Current Liabilities at $26.9 billion in Q1 2026, $28.3 billion in Q4 2025, and $28.6 billion in Q3 2025.